image
Healthcare - Biotechnology - NASDAQ - US
$ 41.11
0.171 %
$ 2.45 B
Market Cap
15.0
P/E
BALANCE SHEET
358 M ASSETS
44.38%
21.3 M LIABILITIES
-97.29%
337 M EQUITY
162.72%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Protagonist Therapeutics, Inc.
image
Current Assets 356 M
Cash & Short-Term Investments 342 M
Receivables 10.3 M
Other Current Assets 3.63 M
Non-Current Assets 2.37 M
Long-Term Investments 0
PP&E 2.15 M
Other Non-Current Assets 225 K
Current Liabilities 21.3 M
Accounts Payable 772 K
Short-Term Debt 2.28 M
Other Current Liabilities 18.2 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
ASSETS
Cash & Cash Equivalents 186.7 125.7 123.7 117.4 33.0 82.2 106.0 21.1 4.1 9.3
Short Term Investments 154.9 111.6 203.2 188.5 100.0 46.6 38.0 56.5 7.9 0
Receivables 10.3 52 K 1.6 2.4 6.8 6.5 3.2 2.2 0.7 0.5
Inventory 0 94 K 8.5 4.0 4.8 2.1 (8.7) (7.7) 1.3 10 K
Other Current Assets 3.6 5.7 12.3 7.4 5.5 4.1 5.1 3.4 1.6 56 K
Total Current Assets 355.6 237.4 340.7 315.6 145.3 137.5 150.9 83.2 14.2 9.9
PP&E 2.1 4.6 6.7 6.4 7.7 0.9 0.9 0.6 0.6 0.4
Intangible Assets 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0.2 0.2 2.0 0.5 0.5 11.5 10.2 30 K 0
Other Long Term Assets 0.2 5.7 0 0.5 0.5 0.5 0.5 34 K 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0
Total Assets 358.0 247.9 347.7 324.5 154.9 139.5 163.7 94.0 14.8 10.3
LIABILITIES
Accounts Payable 0.8 3.6 1.6 3.1 2.8 5.7 1.3 1.2 1.2 0.3
Short Term Debt 2.3 5.0 4.4 2.9 2.5 0 0 0 0 0
Other Current Liabilities 18.2 22.5 36.4 19.8 12.4 12.2 9.5 5.3 1.9 1.0
Total Current Liabilities 21.3 31.2 44.0 40.2 35.4 26.2 42.6 6.4 3.1 1.4
Long Term Debt 0 1.1 3.7 4.5 15.8 0 0 0 0 0
Deferred Tax Income 0.2 0 0 1.0 1.3 0 0 0 0 0
Other Liabilities (0.2) 0 0 0.1 0 0.8 0.5 0 2.1 1.0
Total Liabilities 21.3 784.7 47.7 44.9 75.0 27.0 43.1 6.4 5.2 2.4
EQUITY
Common Stock 1 K 0 0 0 0 0 0 0 0 0
Retained Earnings (615.7) (536.8) (409.4) (283.8) (217.7) (140.5) (101.5) (64.6) (27.4) (12.6)
Other Accumulative Comprehensive Income/Loss (0.1) (0.4) (0.3) 28 K (0.2) (0.2) 6 K (0.2) (0.1) 100 K
Total Equity 336.7 (536.8) (409.4) (283.8) (217.7) (140.5) (101.5) (64.6) 9.6 8.0
Total Liabilities and Equity 358.0 247.9 (361.7) (238.9) (142.7) (113.5) (58.4) (58.2) 14.8 10.3
SHARES OUTSTANDING
Common Shares Outstanding 56.8 49.0 46.3 34.4 25.9 22.4 17.7 6.5 5.9 5.9